Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3334 (110th)

SMA Treatment Acceleration Act

referredUnited States· United States Congress· EN

Introduced

2 August 2007

Last action

2 August 2007 · Introduced

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Kennedy, Patrick J. [D-RI-1], Rep. Cantor, Eric [R-VA-7], Rep. Goode, Virgil H., Jr. [R-VA-5], Rep. Boren, Dan [D-OK-2], Rep. Eshoo, Anna G. [D-CA-18], Rep. Wynn, Albert Russell [D-MD-4], Rep. Marshall, Jim [D-GA-8], Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Cooper, Jim [D-TN-5], Rep. Ros-Lehtinen, Ileana [R-FL-27], Rep. Baird, Brian [D-WA-3], Rep. Wolf, Frank R. [R-VA-10], Rep. Gordon, Bart [D-TN-6], Rep. Drake, Thelma D. [R-VA-2], Rep. Young, C. W. Bill [R-FL-13], Rep. Boucher, Rick [D-VA-9], Rep. Tiberi, Patrick J. [R-OH-12], Rep. Peterson, Collin C. [D-MN-7], Rep. Shays, Christopher [R-CT-4], Rep. McHugh, John M. [R-NY-23], Rep. Kingston, Jack [R-GA-1], Rep. Davis, Tom [R-VA-11], Rep. Castor, Kathy [D-FL-14], Rep. Sestak, Joe [D-PA-7], Rep. Westmoreland, Lynn A. [R-GA-3], Rep. Forbes, J. Randy [R-VA-4], Rep. Pryce, Deborah [R-OH-15], Rep. Kuhl, John R. "Randy", Jr. [R-NY-29], Rep. Stark, Fortney Pete [D-CA-13], Rep. Moran, James P. [D-VA-8], Rep. Ferguson, Mike [R-NJ-7], Rep. Langevin, James R. [D-RI-2], Rep. Wilson, Heather [R-NM-1], Sen. Kirk, Mark Steven [R-IL], Rep. Clarke, Yvette D. [D-NY-9], Rep. Towns, Edolphus [D-NY-10], Rep. Ross, Mike [D-AR-4], Rep. Maloney, Carolyn B. [D-NY-12], Rep. Meeks, Gregory W. [D-NY-5], Rep. Hulshof, Kenny C. [R-MO-9], Rep. Price, Tom [R-GA-6], Rep. Hooley, Darlene [D-OR-5], Sen. Baldwin, Tammy [D-WI], Rep. Alexander, Rodney [R-LA-5], Rep. Dicks, Norman D. [D-WA-6], Rep. Scott, Robert C. "Bobby" [D-VA-3], Rep. Walberg, Tim [R-MI-5], Rep. Pickering, Charles W. "Chip" [R-MS-3]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

SMA Treatment Acceleration Act - Requires the Director of the National Institutes of Health (NIH) to upgrade and unify existing spinal muscular atrophy (SMA) clinical trial sites to establish a national clinical trials network for SMA. Requires the Director of NIH to ensure that such network: (1) conducts coordinated, multisite, clinical trials of pharmacological approaches to the treatment of SMA; and (2) rapidly and effectively disseminates scientific findings to the field. Requires the Director of NIH to: (1) establish an SMA data coordinating center; and (2) expand and intensify NIH programs with respect to preclinical translation research and medicinal chemistry related to SMA. Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enhance and provide ongoing support to the existing SMA patient registry to provide for expanded research on the epidemiology of SMA. Directs the Secretary to ensure the collection and analysis of longitudinal data related to individuals of all ages with SMA. Requires the Secretary to establish the Spinal Muscular Atrophy Coordinating Committee to: (1) coordinate activities across NIH and with other federal health programs and activities relating to SMA; and (2) conduct a study to identify barriers to the development of drugs for treating SMA and similar genetic disorders. Requires the Director of NIH to establish a trans-National Institutes of Health cooperative research initiative on SMA to ensure the success of the SMA projects led by the National Institute of Neurological Disorders and Stroke. Requires the Secretary to submit recommendations to Congress to improve and expand on incentives provided under the Orphan Drug Act and related statutes to promote SMA drug development.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 2 August 2007

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 2 August 2007

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  3. 2 August 2007

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 2 August 2007

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 2 August 2007

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 2 August 2007

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 2 August 2007

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 87 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.